Leukemia/Benign Hematology Assistant or Associate Professor

Title

• Leukemia/Benign
• Hematology
• Assistant or
• Associate
• Professor
• Job
• Type:
• Regular
• Company:
• Roswell
• Park
• Comprehensive
• Cancer
• Center
• Department:
• Department of
• Medicine -
• Leukemia
• Time
• Type:
• Full time
• Weekly
• Hours: 40
• FTE: 1
• Shift: First Shift (United States of America) Summary:

About the Role

• The Department of Medicine at Roswell Park Comprehensive Cancer Center is seeking full-time physicians to join our Leukemia and Benign Hematology services. This is an exceptional opportunity to practice within a highly collaborative academic environment where clinical excellence, translational research, and scientific innovation converge to improve outcomes for patients with complex hematologic diseases. Working alongside nationally recognized leaders in leukemia, immunotherapy, and cellular therapy, the successful candidate will contribute to innovative treatment strategies and help shape the future of hematologic cancer care. This role is ideal for physicians who are passionate about patient-centered medicine, intellectually curious, and eager to participate in cutting-edge clinical research and program development. As part of an NCI-Designated Comprehensive Cancer Center, physicians benefit from a deeply integrated multidisciplinary environment dedicated to advancing groundbreaking therapies and delivering compassionate, evidence-based care. What You’ll Do
• Provide comprehensive care for patients with leukemia and benign hematologic disorders across inpatient and outpatient settings
• Collaborate within a multidisciplinary team to deliver coordinated, high-quality patient-centered care
• Participate in inpatient consultative services, outpatient clinics, and longitudinal disease management
• Develop individualized treatment plans utilizing evidence-based and emerging therapeutic approaches
• Participate in a robust clinical trials portfolio, including early-phase and investigator-initiated studies
• Engage in innovative immunotherapy, cellular therapy, and translational research initiatives
• Collaborate with clinical, translational, and basic science investigators across Roswell Park
• Contribute to the advancement of novel treatment strategies and emerging therapies in hematologic malignancies and benign hematology
• Support the continued growth and development of leukemia and benign hematology programs
• Contribute to initiatives focused on myeloproliferative neoplasms and non-malignant hematologic disorders
• Help expand clinical, research, and academic initiatives aligned with institutional priorities
• Work closely with advanced practice providers, research coordinators, nurses, and multidisciplinary care teams
• Participate in the academic mission through mentorship, teaching, and scholarly engagement
• Foster a collegial and collaborative environment grounded in innovation, compassion, and continuous improvement
• Support a culture aligned with High Reliability Organization principles emphasizing safety, accountability, and teamwork About the Department The Leukemia and Hematologic Malignancies programs at Roswell Park Comprehensive Cancer Center are nationally recognized for advancing innovative therapies, cellular therapy, immunotherapy, and translational cancer research. Faculty collaborate closely across hematologic oncology, bone marrow transplantation, infectious diseases, pathology, genomics, and investigational therapeutics to deliver cutting-edge care for patients with complex hematologic diseases. As part of an NCI-Designated Comprehensive Cancer Center, the department offers access to extensive clinical trial infrastructure, translational science resources, and a deeply collaborative academic environment committed to improving patient outcomes through discovery and innovation. Why You’ll Love Working Here
• Join the nation’s first cancer center and an NCI-Designated Comprehensive Cancer Center committed to transforming cancer care, research, and education
• Collaborate within a highly interdisciplinary academic environment dedicated to innovation, mentorship, and scientific discovery
• Access robust institutional research infrastructure, including Biostatistics, Biomedical Research Informatics, Bioinformatics, and the Data Bank and Biorepository Shared Resources
• Utilize precision oncology and epidemiologic data resources through ORIEN (Oncology Research Information Exchange Network)
• Work alongside passionate colleagues deeply committed to community outreach, engagement, and health equity
• Opportunity for an academic appointment with the University at Buffalo Jacobs School of Medicine and Biomedical Sciences
• Thrive in Buffalo, New York — a welcoming, affordable, and culturally vibrant city with a growing medical and research corridor What You’ll Bring
• MD, DO, or equivalent degree with training and expertise in Hematology and/or Medical Oncology
• Passion for delivering exceptional patient-centered care in leukemia and benign hematology
• Interest in clinical trials, immunotherapy, cellular therapy, and innovative treatment approaches
• A collaborative mindset and the ability to thrive within a multidisciplinary academic environment
• Commitment to academic medicine, continuous learning, and scientific advancement
• Interest in translational research and contributing to the development of emerging therapies
• Executive presence, emotional intelligence, and strong communication and team-building skills
• Passion for mentorship, education, and supporting the next generation of clinicians and physician-scientists
• Dedication to fostering a culture grounded in innovation, inclusion, accountability, compassion, safety, and High Reliability Organization principles Qualifications: Required Education and Experience The successful candidate(s) will be clinical investigator(s) at the Assistant to full Professor level with demonstrated excellence in clinical care and an interest in participating and/or leading clinical trials. Applicants must hold MD or MD/PhD degrees, be board-certified in Internal Medicine and board-certified or eligible in Medical Oncology and/or Hematology, and be able to meet medical licensure requirements in New York State. NOTE: Required degrees must have been granted by an accredited college or university or one recognized by Roswell Park Comprehensive Cancer Center as following acceptable educational practices. Equal Employment Opportunity Statement Roswell Park Cancer Institute Corporation (RPCIC) and Health Research Inc. (HRI) Roswell Park Division believe that all persons are entitled to equal employment opportunities, and we do not discriminate against our employees, applicants or job seekers because of their race, color, religion, sex, sexual orientation, gender identity or expression, national origin, creed, age, disability, pregnancy-related condition, military or veteran status, marital or familial status, domestic violence victim status, citizenship status, genetic information, individual’s relationship or association with a member of a protected category or any other protected group status as defined by law. Reasonable Accommodation Request RPCIC and HRI are committed to working with and providing reasonable accommodation to individuals with disabilities. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the employment process, please email HR-PayAndBenefits@RoswellPark.org and let us know the nature of your request and your contact information. Our Core Values RPCIC and HRI are committed to providing an environment where patients, families, employees and community are treated with courtesy and respect. We support an inclusive environment that nurtures the talents, skills and abilities of each individual to embody and reflect our core values: Innovation, Integrity, Teamwork, Commitment, Compassion and Respect. Historical Compensation Information Statement Pursuant to Executive Order 161, no State entity, as defined by the Executive Order, is permitted to ask, or mandate, in any form, that an applicant for employment provide his or her current compensation, or any prior compensation history, until such time as the applicant is extended a conditional offer of employment with compensation. If such information has been requested from you before such time, please contact the Governor’s Office of Employee Relations at (518) 474-6988 or via email at info@goer.ny.gov. Welcome to Roswell Park Comprehensive Cancer Center. One of the largest employers in Western New York, Roswell Park has over 3,500 employees and is the only National Cancer Institute-designated comprehensive cancer center in New York outside of New York City. Founded in 1898 by Dr. Roswell Park as America's first cancer center, Roswell Park set the standard for cancer centers across the country and world to follow. Equipped with the best facilities and the single objective of curing cancer, we have the sharpest and most creative minds working together in the classroom, laboratory and clinic to accelerate discovery and speed the delivery of promising new cancer treatments. The Institute is recognized by the National Cancer Institute (NCI) as one of only 51 Comprehensive Cancer Centers in the U.S. This designation signifies that all research, treatment and educational programs meet rigorous national standards and that the Institute has contributed fundamentally to the fight against cancer. Roswell Park is also a member of the National Comprehensive Cancer Network (NCCN), an alliance of the nation's leading cancer centers. A not-for-profit organization, the NCCN brings together the best minds in science to engineer continuous quality improvements in cancer care, improves the effectiveness of cancer care delivery through the ongoing collection and analysis of outcome data on a national basis, enhances communications and collaboration among member institutions, offers access to the latest, most promising clinical trials, and provides best practice guidelines and measurement tools. Roswell Park has achieved accreditation from the The Joint Commission (TJC) as a result of its demonstrated compliance with TJC's nationally recognized health care standards. The innovative quality of our faculty’s research has earned Roswell Park a place among the National Cancer Institute’s top grantees. Over the past century, Roswell Park has been the source of historic breakthroughs in the field of oncology. Roswell Park initiated the nation’s first chemotherapy research program. Roswell Park conducted some of the earliest studies linking smoking to lung cancer. Roswell Park developed the PSA test for prostate-cancer screening. Roswell Park developed photodynamic therapy (PDT), approved by the FDA for the treatment of esophageal cancer and non-small cell lung cancer, and precancerous lesions in patients with Barrett's esophagus. Roswell Park is now developing the second generation of PDT drugs. Roswell Park geneticists created the gene library used to map and sequence the human genome. An Roswell Park geneticist was part of the research team involved in the international effort.